Susan Hoe is a Principal Scientist II at Gilead Sciences, specializing in the development of pharmaceutical inhalation products. With over six years of industry experience and seven years in academia, they have contributed significantly as a CMC lead in advancing novel medicines through early-stage development for metered dose inhaler (pMDI) and dry powder inhaler (DPI) products. Susan has led complex projects in inhalation product development, leveraging their expertise in particle engineering and spray drying technologies. They hold a PhD in Pharmaceutical Sciences from the University of Sydney and have been recognized as a subject matter expert in the field.
This person is not in any teams
This person is not in any offices